Swaminathan, Soumya <br/><br/>
Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Oct 2011 
 - 716-24 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1093/cid/cir447  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alkynes<br/>Anti-HIV Agents--administration & dosage<br/>Antiretroviral Therapy, Highly Active--adverse effects<br/>Antitubercular Agents--administration & dosage<br/>Benzoxazines--administration & dosage<br/>CD4 Lymphocyte Count<br/>Cyclopropanes<br/>Female<br/>HIV Infections--complications<br/>Humans<br/>India<br/>Liver Function Tests<br/>Male<br/>Middle Aged<br/>Mycobacterium tuberculosis--isolation & purification<br/>Nevirapine--administration & dosage<br/>Sputum--microbiology<br/>Treatment Outcome<br/>Tuberculosis--complications<br/>Viral Load